The Staphylococcus Aureus Toxins and its Pathogenesis: A Review
Keywords:
Epidemiology, Pathogenesis, Staphylococcus aureus, ToxinsAbstract
Staphylococcus aureus is a grave community-acquired and nosocomial pathogen related to elevated levels of morbidity and mortality and produces a high number of toxins and other virulence agents. So, our review focuses on how S. aureus begins, colonizes, and causes the infection and upon the main determinants involved. This bacterium toxins included different types like (Alpha, Beta, Gamma, and Delta) Hemolysins, Leukotoxins, Staphylococcal Enterotoxins (SEs), Exfoliate Toxins (ETs) , Toxic-Shock Syndrome Toxin (TSST) and Toxin-antitoxin (TA) systems.. Studying the determinants of staphylococcal virulence and determining its structure, function, and epidemiology will facilitate the development of strategies to eliminate its resistance to antibiotics, especially in the absence of an anti- S. aureus vaccine.
References
Tong, S.Y.; Davis, J.S.; Eichenberger, E.; Holland, T.L., Fowler, V.G.,Jr.; "Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management". Clin. Microbiol. Rev., 28(3): 603–661, 2015.
Stryjewski, M.E.; Corey G.R.; "Methicillin-resistant Staphylococcus aureus: an evolving pathogen". Clinic. Infect. Dis., 58(1):S10–S19, 2014.
Guo, Y.; Song, G.; Sun, M.; Wang, J.; Wang, Y.; "Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus". Front.Cell Infect. Microbiol., 10: 107, 2020.
Yunlei, G.; Guanghui, S.; Meiling, S.; Juan, W.; Yi, W.; "Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus". Front.Cell Infect. Microbiol. , 10 (107):1-11, 2020.
Missiakas, D.; Winstel, V.; "Selective Host Cell Death by Staphylococcus aureus: A Strategy for Bacterial Persistence". Front. Immunol., 11(621733) :1-15,2021.
Rasigade, J.P.; Vandenesch, F.; "Staphylococcus aureus: a pathogen with still unresolved issues". Infect. Genet. Evol., 21: 510-4, 2014.
Sapkota, J.; Sharma, M.; Jha, B.; Bhatt, C.P.; "Prevalence of Staphylococcus aureus Isolated from Clinical Samples in a Tertiary Care Hospital: A Descriptive Cross-sectional Study". J. Nepal. Med. Assoc., 57(220): 398–402, 2019.
Timothy, J.F.; "Antibiotic resistance in Staphylococcus aureus. Current status and future prospects". FEMS Microbiol. Rev., 41(3): 430–449, 2017.
Kadhum, H.H.; Abood, Z.H.; " Staphylococcus aureus Incidence in Some Patients with a Topic Dermatitis in Baghdad City". Iraqi J. Biotech., 21(2): 13-20 ,2022.
Hussein, N.; Salih, R.S.; Rasheed, N.A.; "Prevalence of Methicillin-Resistant Staphylococcus aureus in Hospitals and Community in Duhok, Kurdistan Region of Iraq". Int. J. Infect., 6(2): e89636, 2019.
Rasheed, N.A.; Hussein, N.R.; "Characterization of different virulent factors in methicillin-resistant Staphylococcus aureus isolates recovered from Iraqis and Syrian refugees in Duhok city, Iraq". PloS one, 15(8): e0237714, 2020.
Al-Dahbi, A.M.; Al-Mathkhury, H.J.; “Distribution of Methicillin Resistant Staphylococcus aureus in Iraqi patients and Healthcare Workers”; Iraqi J. Sci., 54(2): 293-300, 2013.
Kobayashi, S.D.; Malachowa, N.; DeLeo, F.R.; "Pathogenesis of Staphylococcus aureus abscesses". America. J. pathol., 185(6), 1518–1527,2015.
Rhee, Y.; Aroutcheva, A.;Hota, B.; et al.; "Evolving Epidemiology of Staphylococcus aureus Bacteremia". Infect. Con. Hosp. Epidemiol, 36:1417, 2015.
Kwiecinski, J.M.; Horswill, A.R.; "Staphylococcus aureus bloodstream infections: pathogenesis and regulatory mechanisms". Curr. Opin. Microbial., 53: 51–60, 2020.
Nikmanesh, Y.; Foolady Azarnaminy, A.; Avishan, P.; et al.; "A Middle East systematic review and meta-analysis of prevalence and antibiotic susceptibility pattern in MRSA Staphylococcus aureus isolated from patients with cystic fibrosis". J. Health. Popul. Nutr., 41(26), 2022.
Wu, Q.; Sabokroo, N.; Wang Y.; Hashemian M.; Karamollahi, S.; Kouhsari, E.; "Systematic review and meta-analysis of the epidemiology of vancomycin-resistance Staphylococcus aureus isolates". Antimicrob. Resist. Infect. Control, 10(1):101, 2021.
Kwiecinski J.M.; Horswill, A.R.; "Staphylococcus aureus bloodstream infections: pathogenesis and regulatory mechanisms". Curr. Opin. Microbial., 53:51–60, 2020.
Gnanamani, A.; Hariharan, P.; Paul-Satyaseela, M.; “Staphylococcus aureus: Overview of Bacteriology, Clinical Diseases, Epidemiology, Antibiotic Resistance and Therapeutic Approach”. Front. Staphylococcus aureus, 2017.
Liu, G.Y.; "Molecular pathogenesis of Staphylococcus aureus infection". Pediatr Res., 65(5 Pt 2): 71R–77R, 2009.
Sakr, A.; Brégeon, F.; Mège, J.L.; Rolain, J.M.; Blin, O.; "Staphylococcus aureus Nasal Colonization: An Update on Mechanisms, Epidemiology, Risk Factors, and Subsequent Infections". Front. Microbial., 9: 2419,2018.
Dunyach-Remy, C.; Ngba, E.C.; Sotto, A.; Lavigne J.P.; "Staphylococcus aureus Toxins and Diabetic Foot Ulcers: Role in Pathogenesis and Interest in Diagnosis". Tox., 8(7): 209, 2016.
Malachowa, N.; DeLeo, F.R.; "Mobile genetic elements of Staphylococcus aureus". Cell. Mol. Life Sci., 67(18): 3057–3071, 2010.
Takeuchi N.; Hamada-Zhu, S.; Suzuki, H.; "Prophages and plasmids can display opposite trends in the types of accessory genes they carry". Proc. R. Soc. B., 290: 10882, 2023.
Cheung, G.Y.C.; Bae, J.S.; Otto, M.; "Pathogenicity and virulence of Staphylococcus aureus". Virul., 12(1): 547–569, 2021.
Tam, K.; Torres, V.J.; "Staphylococcus aureus Secreted Toxins and Extracellular Enzymes". Microbiol. Spectr., 7(2): 3- 39, 2019.
Schwendimann, L.; "Evaluation and prediction of staphylococcal enterotoxins. Human health and pathology".(Ph.D. Thesis), Université Paris-Est:255, 2021(In English).
Partridge, S.R.; Kwong, S.M..; Firth, N.; Jensen, S.O.; "Mobile Genetic Elements Associated with Antimicrobial Resistance". Clin. Microbiol. Rev., 31(4): e00088-17, 2018.
Dupuis, M.È.; Villion, M.; Magadán, A.H.; Moineau, S.; "CRISPR-Cas and restriction-modification systems are compatible and increase phage resistance". Nat. Comm., 4: 2087, 2013.
Turner, N.A.; Sharma-Kuinkel, B.K.; Maskarinec, S.A.; Eichenberger, E.M.; Shah, P.P.; Carugati, M.; Holland, T.L.; Fowler, V.G.; "Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research". Nat. Rev. Microbiol., 17(4): 203–218,2019.
Kayan, T.K.; Torres, V.J.; "Staphylococcus aureus Secreted Toxins and Extracellular Enzymes". Microbiol. Spect.,7(2): 16,2019.
Cheung, G.Y.; Joo, H. S.; Chatterjee, S.S.; Otto, M.; "Phenol-soluble modulins-critical determinants of staphylococcal virulence". FEMS Microbiol. Rev., 38(4): 698–719, 2014
Vandenesch, F.; Lina, G.; Henry, T.; "Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors?". Front. Cell. Infect. Microbiol., 2: 12, 2012.
Wang, L.J.; Yang, X.; Qian, S.Y.; Liu, Y.C.; Yao, K.H.; Dong, F.; Song, W.Q.; "Identification of hemolytic activity and hemolytic genes of Methicillin-resistant Staphylococcus aureus isolated from Chinese children". Chin. Med. J., 133(1): 88–90, 2020.
Su, M.; Lyles, J.T.; Petit, R.A.; Peterson, J.; Hargita, M.; Tang, H.; Solis-Lemus, C.; Quave, C.L.; Timothy, D.; "Genomic analysis of variability in Delta-toxin levels between Staphylococcus aureus strains". Peer J., 8: e8717, 2020
Liu, Y.; Shi, D.; Guo, Y.; Li, M.; Zha, Y.; Wang, Q. et al.; "Dracorhodin Perochlorate attenuates Staphylococcus aureus USA300 virulence by decreasing alpha-toxin expression". W. J. Microbiol. Biotechnol., 33: 17, 2017.
Kong, C.; Neoh, H.M.; Nathan, S.; "Targeting Staphylococcus aureus Toxins: A Potential form of Anti-Virulence Therapy". Tox., 8(3): 72, 2016.
András, N.S.; Jos, A.G.; Victor, J.T.; "Leukocidins: staphylococcal bi component pore-forming toxins find their receptors. Nat. Rev. Microbial., 15: 435-447, 2017.
Ullah, A.; Khan, A.; Al-Harrasi, A.; Ullah, A.; Shabbir, A.; "Three-Dimensional Structure Characterization and Inhibition Study of Exfoliative Toxin D From Staphylococcus aureus". Front. Pharmacol., 13: 1-17, 2022.
Bukowski, M.; Wladyka, B.; Dubin, G.; "Exfoliative toxins of Staphylococcus aureus". Tox., 2(5): 1148–1165, 2010.
Oliveira, D.; Borges, A.; Simões, M.; "Staphylococcus aureus Toxins and Their Molecular Activity in Infectious Diseases". Tox., 10(6): 252, 2018.
Grumann, D.; Nübel, U.; Bröker, B.M.; "Staphylococcus aureus toxins—Their functions and genetics". Infect. Genet. Evol., 21: 583–592, 2014.
Argudín, M.Á.; Mendoza, M.C.; Rodicio, M.R.; "Food poisoning and Staphylococcus aureus enterotoxins". Tox., 2(7): 1751–1773, 2010.
Kulhankova, K.; King, K.; Salgado-Pabo´n W.; "Staphylococcal toxic shock syndrome: superantigen-mediated enhancement of endotoxin shock and adaptive immune suppression". J. Immunol. Res.,: 1-7, 2014.
Zhang, H.; Jiaxin, C.; Zhien, H.; Xianchun, Z.; "Molecular Epidemiology of Staphylococcus aureus in a Tertiary Hospital in Anhui, China: ST59 Remains a Serious Threat". Infect. Drug Resist.,16: 961-976, 2023.
Xu, J.; Wang, Y.; Liu, F.; Duan, G.; Yang, H.; "Genome mining reveals the prevalence and extensive diversity of toxin–antitoxin systems in Staphylococcus aureus". Front. Microbiol., 14: 1-10, 2023.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Al-Nahrain Journal of Science
This work is licensed under a Creative Commons Attribution 4.0 International License.
.jpg)
